PLEGRIDY® (Peginterferon Beta-1a) Three-Year Data Presented at AAN Annual Meeting Support Long-Term Safety and Efficacy in Multiple Sclerosis Patients
Biogen, 21 Apr 2015
Accessed on 21 Apr 2015 from http://biogen.newshq.businesswire.com/press-release/neurology/plegridy-peginterferon-beta-1a-three-year-data-presented-aan-annual-meeting-.